Skip to main content
. 2015 Mar 9;11(3):537–544. doi: 10.1080/21645515.2015.1011026

Table 3.

Predictors of off-label high-dose influenza vaccine use among adults aged 18–64 y, 2010–2012

% High-dose influenza vaccine % Standard influenza vaccine Multivariable adjusted OR (95% CI)
Total (N) 31,989 8,608,982
Age
18–35 16.8 19.0 0.83 (0.80, 0.87)
36–50 27.7 30.7 0.83 (0.81, 0.86)
51–64 55.5 50.3 Reference
Male sex 44.5 41.2 1.08 (1.05, 1.10)
Physician type
Family practice doctor 27.6 36.1 0.62 (0.61, 0.64)
Internal medicine doctor 25.3 20.0 Reference
Other 14.8 14.1 0.92 (0.89, 0.96)
Specialist 15.7 13.7 1.01 (0.98, 1.05)
Hospital doctor 1.3 1. 0.55 (0.50, 0.60)
Nurse 0.6 3.2 0.17 (0.14, 0.19)
Pharmacist 0.5 4.8 0.08 (0.07, 0.10)
Region
Northeast 17.6 22.0 Reference
North central 34.2 24.9 1.45 (1.40, 1.50)
South 34.6 34.5 1.40 (1.35, 1.44)
West 12.0 16.6 0.98 (0.94, 1.03)
Unknown 1.6 2.0 0.98 (0.90, 1.08)
Immune related comorbidities
Immunesuppression (HIV, cancer, autoimmune, transplant) 13.4 10.5 1.23 (1.18, 1.27)
Heart disease* 13.1 9.1 1.30 (1.25, 1.35)
Chronic liver disease 1.8 1.4 1.08 (0.99, 1.18)
Chronic lung disease 11.4 8.9 1.25 (1.20, 1.29)
Other comorbidities
Diabetes 19.0 14.1 1.28 (1.24, 1.32)
Hypertension 34.2 28.2 1.17 (1.14, 1.21)

*IHD or MI